Loading...

Notice

Check the various announcements of oncoMASTER.

[oncoMASTER press release] “Yuhan Corporation adds anticancer drug partner…invests KRW 2 billion in oncoMASTER” (2022. 08. 20. Daily Farm)

2024.02.07 14:45

[oncoMASTER press release] “Yuhan Corporation adds anticancer drug partner…invests KRW 2 billion in oncoMASTER” (2022. 08. 20. Daily Farm)

“Yuhan Corporation adds anticancer drug partner…invests KRW 2 billion in oncoMASTER”

Onmaster has a cancer precision medicine platform... Started by a professor at Korea University School of Medicine

Maximizing synergy in R&D with existing partners such as Janssen, Scotec, and Genosco

 

link

http://www.dailypharm.com/Users/News/NewsView.html?ID=291060&REFERER=NP

Source: Daily Farm (Reporter Seokjun Lee_2022. 08. 20)


ONCOCROSS Co., Ltd.

Business registration number: 482-86-00109 | CEO: Yi Rang KIM / Jihoon KANG

Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)

Email: oncocross@oncocross.com

ⓒ ONCOCROSS CO., LTD. All Rights Reserved.

온코마스터 로고.